Kura Oncology, Inc.KURANASDAQ
Loading
EBITDA Margin Over TimeContracting
Percentile Rank0
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

Latest
-429.78%
↓ 477% vs avg
Percentile
P0
Near historical low
Streak
2 yr
Consecutive declineContracting
Average
-74.43%
Historical baseline
PeriodValueYoY Change
TTM-429.78%-36.6%
2024-314.57%-
20230.00%-
20220.00%-
20210.00%-
20200.00%-
20190.00%-
20180.00%-
20170.00%-
20160.00%-